Biotron Limited (BIT.AX)
AUD 0.0
(50.0%)
AUD 0.0
(50.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 737.5 Thousand AUD | -23.38% |
| 2023 | 962.49 Thousand AUD | 18.31% |
| 2022 | 813.56 Thousand AUD | 75.52% |
| 2021 | 463.51 Thousand AUD | -45.67% |
| 2020 | 853.19 Thousand AUD | 104.11% |
| 2019 | 417.99 Thousand AUD | 23.78% |
| 2018 | 337.7 Thousand AUD | -45.49% |
| 2017 | 619.51 Thousand AUD | 78.89% |
| 2016 | 346.31 Thousand AUD | -26.81% |
| 2015 | 473.17 Thousand AUD | -0.31% |
| 2014 | 474.64 Thousand AUD | 21.37% |
| 2013 | 391.07 Thousand AUD | 103.5% |
| 2012 | 192.17 Thousand AUD | -21.34% |
| 2011 | 244.32 Thousand AUD | 74.16% |
| 2010 | 140.28 Thousand AUD | -36.9% |
| 2009 | 222.33 Thousand AUD | -47.56% |
| 2008 | 423.94 Thousand AUD | 160.05% |
| 2007 | 163.02 Thousand AUD | -48.75% |
| 2006 | 318.1 Thousand AUD | 112.24% |
| 2005 | 149.87 Thousand AUD | -2.25% |
| 2004 | 153.33 Thousand AUD | 3.55% |
| 2003 | 148.07 Thousand AUD | 3.63% |
| 2002 | 142.89 Thousand AUD | 28.22% |
| 2001 | 111.44 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 737.5 Thousand AUD | -23.38% |
| 2024 Q2 | 626.16 Thousand AUD | 0.0% |
| 2024 Q4 | 737.5 Thousand AUD | 0.0% |
| 2023 Q4 | 962.49 Thousand AUD | 0.0% |
| 2023 Q2 | 805.65 Thousand AUD | 0.0% |
| 2023 FY | 962.49 Thousand AUD | 18.31% |
| 2022 Q4 | 813.56 Thousand AUD | 0.0% |
| 2022 Q2 | 628.65 Thousand AUD | 0.0% |
| 2022 FY | 813.56 Thousand AUD | 75.52% |
| 2021 FY | 463.51 Thousand AUD | -45.67% |
| 2021 Q4 | 463.51 Thousand AUD | 0.0% |
| 2021 Q2 | 681.81 Thousand AUD | 0.0% |
| 2020 Q4 | 853.19 Thousand AUD | 0.0% |
| 2020 FY | 853.19 Thousand AUD | 104.11% |
| 2020 Q2 | 411.94 Thousand AUD | 0.0% |
| 2019 Q2 | 377.23 Thousand AUD | 0.0% |
| 2019 Q4 | 417.99 Thousand AUD | 0.0% |
| 2019 FY | 417.99 Thousand AUD | 23.78% |
| 2018 Q2 | 368.59 Thousand AUD | 0.0% |
| 2018 FY | 337.7 Thousand AUD | -45.49% |
| 2018 Q4 | 337.7 Thousand AUD | 0.0% |
| 2017 Q4 | 619.51 Thousand AUD | 0.0% |
| 2017 FY | 619.51 Thousand AUD | 78.89% |
| 2017 Q2 | 342.03 Thousand AUD | 0.0% |
| 2016 Q4 | 346.31 Thousand AUD | 0.0% |
| 2016 FY | 346.31 Thousand AUD | -26.81% |
| 2016 Q2 | 289.33 Thousand AUD | 0.0% |
| 2015 FY | 473.17 Thousand AUD | -0.31% |
| 2015 Q4 | 473.17 Thousand AUD | 0.0% |
| 2015 Q2 | 273.07 Thousand AUD | 0.0% |
| 2014 Q2 | 362.41 Thousand AUD | 0.0% |
| 2014 FY | 474.64 Thousand AUD | 21.37% |
| 2014 Q4 | 474.64 Thousand AUD | 0.0% |
| 2013 Q3 | 391.07 Thousand AUD | 3.81% |
| 2013 Q2 | 376.73 Thousand AUD | 0.0% |
| 2013 FY | 391.07 Thousand AUD | 103.5% |
| 2013 Q1 | 376.73 Thousand AUD | 96.03% |
| 2013 Q4 | 391.07 Thousand AUD | 0.0% |
| 2012 Q4 | 192.17 Thousand AUD | 0.0% |
| 2012 FY | 192.17 Thousand AUD | -21.34% |
| 2011 FY | 244.32 Thousand AUD | 74.16% |
| 2011 Q4 | 244.32 Thousand AUD | 0.0% |
| 2010 FY | 140.28 Thousand AUD | -36.9% |
| 2010 Q4 | 140.28 Thousand AUD | 0.0% |
| 2009 Q4 | 222.33 Thousand AUD | 0.0% |
| 2009 FY | 222.33 Thousand AUD | -47.56% |
| 2008 Q4 | 423.94 Thousand AUD | 0.0% |
| 2008 FY | 423.94 Thousand AUD | 160.05% |
| 2007 Q4 | 163.02 Thousand AUD | 0.0% |
| 2007 FY | 163.02 Thousand AUD | -48.75% |
| 2006 FY | 318.1 Thousand AUD | 112.24% |
| 2006 Q4 | 318.1 Thousand AUD | 0.0% |
| 2005 FY | 149.87 Thousand AUD | -2.25% |
| 2005 Q4 | 149.87 Thousand AUD | 0.0% |
| 2004 Q4 | 153.33 Thousand AUD | 0.0% |
| 2004 FY | 153.33 Thousand AUD | 3.55% |
| 2003 FY | 148.07 Thousand AUD | 3.63% |
| 2003 Q4 | 148.07 Thousand AUD | 0.0% |
| 2002 FY | 142.89 Thousand AUD | 28.22% |
| 2002 Q4 | 142.89 Thousand AUD | 0.0% |
| 2001 FY | 111.44 Thousand AUD | 0.0% |
| 2001 Q4 | 111.44 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | 79.181% |
| Acrux Limited | 5.68 Million AUD | 87.032% |
| Actinogen Medical Limited | 1.61 Million AUD | 54.344% |
| AnteoTech Limited | 4.07 Million AUD | 81.903% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 69.609% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 64.14% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -140.349% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 86.407% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 78.478% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | 21.67% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -100.167% |
| Biome Australia Limited | 5.37 Million AUD | 86.274% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 80.239% |
| BTC Health Limited | 203.94 Thousand AUD | -261.616% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 94.24% |
| CSL Limited | 27.88 Billion AUD | 99.997% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 91.148% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 97.377% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 37.022% |
| Dimerix Limited | 13.89 Million AUD | 94.692% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 82.561% |
| Hexima Limited | 248.67 Thousand AUD | -196.581% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 29.467% |
| Immuron Limited | 2.84 Million AUD | 74.036% |
| Immutep Limited | 10.97 Million AUD | 93.283% |
| Imugene Limited | 33.14 Million AUD | 97.775% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -70.866% |
| Memphasys Limited | 5.59 Million AUD | 86.812% |
| Nanollose Limited | 465.64 Thousand AUD | -58.385% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 98.275% |
| Noxopharm Limited | 1.28 Million AUD | 42.767% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -760.74% |
| Nyrada Inc. | 855.63 Thousand AUD | 13.806% |
| Orthocell Limited | 22.08 Million AUD | 96.66% |
| PharmAust Limited | 896.6 Thousand AUD | 17.745% |
| Patrys Limited | 691.36 Thousand AUD | -6.674% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 79.424% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 54.641% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 68.287% |
| PYC Therapeutics Limited | 10.18 Million AUD | 92.758% |
| Race Oncology Limited | 1.91 Million AUD | 61.516% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 98.349% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 95.36% |
| Starpharma Holdings Limited | 8.69 Million AUD | 91.521% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.704% |
| Tissue Repair Ltd | 1.35 Million AUD | 45.406% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 92.118% |